James Shin
Stock Analyst at Deutsche Bank
(1.86)
# 3,097
Out of 4,876 analysts
20
Total ratings
44.44%
Success rate
3.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMTX Immatics | Initiates: Buy | $10 | $5.59 | +78.89% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $107.62 | +11.50% | 2 | Feb 18, 2025 | |
| MRK Merck & Co. | Downgrades: Hold | $128 → $105 | $78.83 | +33.20% | 2 | Feb 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,025 → $1,015 | $795.12 | +27.65% | 4 | Nov 4, 2024 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $279.11 | +9.28% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $70.81 | -15.27% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $46.65 | -3.54% | 2 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $33.48 | +79.21% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $186.79 | -19.70% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $521.00 | +53.55% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $2.31 | +332.90% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.80 | +1,401.88% | 1 | Nov 9, 2023 |
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $5.59
Upside: +78.89%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $107.62
Upside: +11.50%
Merck & Co.
Feb 18, 2025
Downgrades: Hold
Price Target: $128 → $105
Current: $78.83
Upside: +33.20%
Eli Lilly and Company
Nov 4, 2024
Maintains: Buy
Price Target: $1,025 → $1,015
Current: $795.12
Upside: +27.65%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $279.11
Upside: +9.28%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $70.81
Upside: -15.27%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $46.65
Upside: -3.54%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $33.48
Upside: +79.21%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $186.79
Upside: -19.70%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $521.00
Upside: +53.55%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.80
Upside: +1,401.88%